Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 204

Results For "ANDA"

2601 News Found

Gut microbiome as a tool in regenerative medicine
Biotech | May 07, 2022

Gut microbiome as a tool in regenerative medicine

Novel approach driven by GN Corp Japan with potentials in neurological illnesses


Lupin receives USFDA approval for Pregabalin and Iloperidone
Drug Approval | May 06, 2022

Lupin receives USFDA approval for Pregabalin and Iloperidone

While Pregabalin will be manufactured at the Aurangabad facility, Iloperidone will be manufactured at the Goa facility


Sawai Man Singh Medical College (SMS), Jaipur collaborates with Intuitive India
Healthcare | May 05, 2022

Sawai Man Singh Medical College (SMS), Jaipur collaborates with Intuitive India

The workshop was organized by the Department of Urology as a first step to enabling government medical colleges in Rajasthan to offer the latest surgical technology


Avantor to create a new manufacturing hub in Singapore
News | May 05, 2022

Avantor to create a new manufacturing hub in Singapore

The new hub, which brings Avantor solutions closer to regional customers and strengthens global supply chain capabilities, will be fully operational early next year


Eugia Pharma receives USFDA approval for Bortezomib
Drug Approval | May 04, 2022

Eugia Pharma receives USFDA approval for Bortezomib

The approved product has a market size of US $ 1172 million for the twelve months ending March 2022, according to IQVIA


Aleor Dermaceuticals receives USFDA approval for Docosanol Cream
Drug Approval | May 04, 2022

Aleor Dermaceuticals receives USFDA approval for Docosanol Cream

Docosanol Cream, 10% (OTC) has an estimated market size of US$60 million for twelve months ending December 2021 according to IQVIA


Gland launches Bortezomib in the US market
Drug Approval | May 04, 2022

Gland launches Bortezomib in the US market

Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma


USFDA concludes inspection of Shilpa Medicare with four observations
News | May 02, 2022

USFDA concludes inspection of Shilpa Medicare with four observations

The inspection was triggered by Shilpa's submission of applications for four ANDA's to seek approval to use this site as an alternate testing laboratory


NHA enlists Pristyn Care as health tech partner for Ayushman Bharat Digital Mission
Healthcare | May 02, 2022

NHA enlists Pristyn Care as health tech partner for Ayushman Bharat Digital Mission

ABDM is a critical integration that leverages an open, interoperable, standards-based digital system that is secure, and maintains confidentiality and privacy of health-related personal information


USFDA approves Rinvoq as an oral treatment for ankylosing spondylitis
Drug Approval | May 01, 2022

USFDA approves Rinvoq as an oral treatment for ankylosing spondylitis

The USFDA approval in AS marks the fifth indication for Rinvoq in chronic immune-mediated diseases